Results 31 to 40 of about 37,432,551 (241)

A minimal physiologically based pharmacokinetic model for high-dose methotrexate [PDF]

open access: yes, 2021
Purpose: High-dose methotrexate (HDMTX) is administered for the treatment of a variety of malignant tumors. Wide intra- and inter-individual variabilities characterize the pharmacokinetics of MTX, which is mostly excreted renally.
Foppoli M., Manca D., Pesenti G.
core   +2 more sources

Application of a Physiologically Based Pharmacokinetic Model to Characterize Time-dependent Metabolism of Voriconazole in Children and Support Dose Optimization

open access: yesFrontiers in Pharmacology, 2021
Background: Voriconazole is a potent antifungal drug with complex pharmacokinetics caused by time-dependent inhibition and polymorphisms of metabolizing enzymes. It also exhibits different pharmacokinetic characteristics between adults and children.
Yahui Zhang   +7 more
doaj   +1 more source

Corrigendum: Development and application of a physiologically-based pharmacokinetic model for ractopamine in goats [PDF]

open access: yesFrontiers in Veterinary Science
Jing Ai   +8 more
doaj   +2 more sources

ATLAS mPBPK: A MATLAB‐Based Tool for Modeling and Simulation of Minimal Physiologically‐Based Pharmacokinetic Models

open access: yesCPT: Pharmacometrics & Systems Pharmacology, 2019
Minimal physiologically‐based pharmacokinetic (mPBPK) models are frequently used to model plasma pharmacokinetic (PK) data and utilize and yield physiologically relevant parameters. Compared with classical compartment and whole‐body physiologically‐based
Panteleimon D. Mavroudis   +2 more
doaj   +1 more source

A best practice framework for applying physiologically‐based pharmacokinetic modeling to pediatric drug development

open access: yesCPT: Pharmacometrics & Systems Pharmacology, 2021
Pediatric physiologically‐based pharmacokinetic (PBPK) models have broad application in the drug development process and are being used not only to project doses for clinical trials but increasingly to replace clinical studies.
Trevor N. Johnson   +3 more
doaj   +1 more source

Structure of pregnancy physiologically based pharmacokinetic (p-PBPK) model.

open access: yes, 2015
Structure of pregnancy physiologically based pharmacokinetic (p-PBPK) model.
Saeed Alqahtani (802779)   +1 more
core   +1 more source

A Physiologically-Based Pharmacokinetic Model for Vancomycin [PDF]

open access: yes, 2015
Vancomycin is an antibiotic used for the treatment of systemic infections. It is given intravenously usually every twelve or twenty-four hours. This particular drug has a medium level of boundedness, with approximately fty percent of the drug being free ...
White, Rebekah
core   +1 more source

Towards a Generic Tool for Prediction of Meropenem Systemic and Infection-Site Exposure: A Physiologically Based Pharmacokinetic Model for Adult Patients with Pneumonia

open access: yesDrugs in R&D, 2019
Objective The objective of this study was to develop a physiologically based pharmacokinetic model for meropenem using a retrograde approach, which could serve as a basis for prediction of the systemic and infection-site drug exposures in different ...
Pauline Thémans   +3 more
doaj   +1 more source

Predicting Pharmacokinetics of Active Constituents in Spatholobi caulis by Using Physiologically Based Pharmacokinetic Models

open access: yesPharmaceuticals
Background/Objectives: Spatholobi Caulis (SPC) is a medicinal plant that mainly grows in China and Southeast Asian countries and commonly used in clinics; the pharmacokinetic characteristics in humans need to be determined.
Xiaoyan Liu   +7 more
doaj   +1 more source

Abbreviations of parameters of the physiologically based pharmacokinetic model for GL, GA and GAM.

open access: yes, 2014
Abbreviations of parameters of the physiologically based pharmacokinetic model for GL, GA and GAM.
Jin Yang (86490)   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy